{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:25:35Z","timestamp":1772821535832,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cld.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T11:36:39Z","timestamp":1721734599000},"page":"601-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alcohol and Metabolic Syndrome Interaction"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2459-9949","authenticated-orcid":false,"given":"Ryuki","family":"Hashida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9818-0983","authenticated-orcid":false,"given":"Pegah","family":"Golabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-577X","authenticated-orcid":false,"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2024.06.002_bib1","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"\u00c5berg","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2024.06.002_bib2","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","article-title":"Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease","volume":"150","author":"Anstee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.06.002_bib3","series-title":"Alcohol consumption per capita from all beverages in the U.S. from 1850 to 2021","year":"2023"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease","volume":"78","author":"\u00c5berg","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0040-1701443","article-title":"Drinking and obesity: alcoholic liver disease\/nonalcoholic fatty liver disease interactions","volume":"40","author":"\u00c5berg","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2024.06.002_bib6","article-title":"Brief intervention for hazardous and harmful drinking: a manual for use in primary care","author":"Babor","year":"2001","journal-title":"World Health Organizaton Department of Mental Health and Substance Abuse"},{"issue":"39","key":"10.1016\/j.cld.2024.06.002_bib7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.15585\/mmwr.mm6939a6","article-title":"Deaths and years of potential life lost from excessive alcohol use - United States, 2011-2015","volume":"69","author":"Esser","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.cld.2024.06.002_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","article-title":"Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis","volume":"29","author":"Rehm","year":"2010","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"10.1016\/j.cld.2024.06.002_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2468-1253(19)30419-4","article-title":"Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study","volume":"5","author":"Abeysekera","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2024.06.002_bib10","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1097\/TP.0000000000004202","article-title":"Alcohol-associated liver disease is now the most common indication for liver transplant waitlisting among young American adults","volume":"106","author":"Philip","year":"2022","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"7","key":"10.1016\/j.cld.2024.06.002_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jacc.2022.04.046","article-title":"Trends and disparities in cardiometabolic health among U.S. Adults, 1999-2018","volume":"80","author":"O\u2019Hearn","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cld.2024.06.002_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijcard.2015.10.218","article-title":"Metabolic syndrome and the risk of sudden cardiac death in middle-aged men","volume":"203","author":"Kurl","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cld.2024.06.002_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.acc.2022.06.002","article-title":"New markers in metabolic syndrome","volume":"110","author":"Son","year":"2022","journal-title":"Adv Clin Chem"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12902-019-0366-3","article-title":"Metabolic syndrome and liver-related events: a systematic review and meta-analysis","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.35946\/arcr.v42.1.13","article-title":"Alcohol use disorder and alcohol-associated liver disease","volume":"42","author":"Ramkissoon","year":"2022","journal-title":"Alcohol Res"},{"key":"10.1016\/j.cld.2024.06.002_bib18","article-title":"Impact of longitudinal alcohol use patterns on long-term risk of cirrhosis among U.S. Veterans with steatotic liver disease","author":"Wong","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s13679-014-0129-4","article-title":"Alcohol consumption and obesity: an update","volume":"4","author":"Traversy","year":"2015","journal-title":"Curr Obes Rep"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.amepre.2017.02.007","article-title":"Heavy drinking in young adulthood increases risk of transitioning to obesity","volume":"53","author":"Fazzino","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cld.2024.06.002_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2458-10-237","article-title":"Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey","volume":"10","author":"Kotronen","year":"2010","journal-title":"BMC Publ Health"},{"issue":"6","key":"10.1016\/j.cld.2024.06.002_bib22","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.06.002_bib23","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/liv.15081","article-title":"Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use","volume":"42","author":"Decraecker","year":"2022","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.cld.2024.06.002_bib25","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep4.1776","article-title":"Associations between alcohol use and liver-related outcomes in a large national cohort of patients with cirrhosis","volume":"5","author":"Pearson","year":"2021","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.cld.2024.06.002_bib26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cgh.2018.11.033","article-title":"Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2024.06.002_bib27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.cgh.2018.01.026","article-title":"Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis","volume":"16","author":"Ajmera","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2024.06.002_bib28","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.amjmed.2022.05.015","article-title":"Alarming trends: mortality from alcoholic cirrhosis in the United States","volume":"135","author":"Termeie","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2024.06.002_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ebiom.2019.03.046","article-title":"Obesity in acute alcoholic hepatitis increases morbidity and mortality","volume":"45","author":"Parker","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2019.07.013","article-title":"Long-term liver-related outcomes of patients with chronic liver diseases in Australia","volume":"18","author":"Huang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hep.32123","article-title":"Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity","volume":"75","author":"Innes","year":"2022","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2024.06.002_bib32","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/liv.14830","article-title":"Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: a population-based study","volume":"41","author":"Pose","year":"2021","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2021.09.030","article-title":"Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus","volume":"76","author":"Mallet","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12876-021-01893-4","article-title":"Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study","volume":"21","author":"Yoshimura","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2024.06.002_bib35","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cgh.2010.06.027","article-title":"Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men","volume":"8","author":"Loomba","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2024.06.002_bib36","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/liv.15256","article-title":"Alcohol-related hepatocellular carcinoma is a heterogenous condition: lessons from a latent class analysis","volume":"42","author":"Costentin","year":"2022","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2024.06.002_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102124","article-title":"Treatment patterns, risk factors and outcomes for patients with newly diagnosed hepatocellular carcinoma in France: a retrospective database analysis","volume":"47","author":"Mathurin","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2024.06.002_bib38","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000352","article-title":"The changing epidemiology of adult liver transplantation in the United States in 2013-2022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease","volume":"8","author":"Younossi","year":"2024","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2022-001083","article-title":"Lower survival and higher rates of cirrhosis in patients with ROUX-EN-Y gastric bypass hospitalised with alcohol-associated hepatitis","volume":"10","author":"Anugwom","year":"2023","journal-title":"BMJ Open Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MCG.0000000000001506","article-title":"Barritt AS 4th. Roux-en-Y gastric bypass is associated with increased hazard for de Novo alcohol-related complications and liver disease","volume":"56","author":"Kim","year":"2022","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.06.002_bib42","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/liv.14805","article-title":"Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse","volume":"41","author":"Mellinger","year":"2021","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2024.06.002_bib43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s10620-022-07591-9","article-title":"Association of previous gastric bypass surgery and patient outcomes in alcohol-associated cirrhosis hospitalizations","volume":"68","author":"Yarra","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.cld.2024.06.002_bib44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/00365521.2022.2085060","article-title":"Validity of fatty liver disease indices in the presence of alcohol consumption","volume":"57","author":"Danielsson","year":"2022","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12072-022-10298-8","article-title":"Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease","volume":"16","author":"Morinaga","year":"2022","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.cld.2024.06.002_bib46","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","article-title":"Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease","volume":"77","author":"Staufer","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.06.002_bib47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2010.12.034","article-title":"Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK","volume":"55","author":"Xu","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.06.002_bib48","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.27921","article-title":"Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1","volume":"62","author":"Chang","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.06.002_bib49","article-title":"Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication","volume":"3","author":"Israelsen","year":"2021","journal-title":"JHEP Rep"},{"issue":"41","key":"10.1016\/j.cld.2024.06.002_bib50","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.15585\/mmwr.mm7041a2","article-title":"Binge drinking among adults, by select characteristics and state - United States, 2018","volume":"70","author":"Bohm","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"170","key":"10.1016\/j.cld.2024.06.002_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005123","article-title":"Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action","volume":"5","author":"Lindtner","year":"2013","journal-title":"Sci Transl Med"},{"issue":"27","key":"10.1016\/j.cld.2024.06.002_bib52","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.4254\/wjh.v7.i27.2703","article-title":"Binge drinking: burden of liver disease and beyond","volume":"7","author":"Llerena","year":"2015","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2012.03.024","article-title":"Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"Dunn","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.06.002_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.744713","article-title":"The effects of modest alcohol consumption on non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"8","author":"Wongtrakul","year":"2021","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.cld.2024.06.002_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049767","article-title":"Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis","volume":"12","author":"Jarvis","year":"2022","journal-title":"BMJ Open"},{"issue":"13","key":"10.1016\/j.cld.2024.06.002_bib56","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3748\/wjg.v24.i13.1440","article-title":"Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis","volume":"24","author":"Kimura","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2024.06.002_bib57","first-page":"147","article-title":"Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD)","volume":"4","author":"Seitz","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.cld.2024.06.002_bib58","article-title":"Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease","author":"Younossi","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.06.002_bib59","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2020.11.004","article-title":"\u201cDual aetiology fatty liver disease\u201d: a recently proposed term associated with potential pitfalls","volume":"74","author":"Moreno","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.002_bib60","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.jhep.2023.07.012","article-title":"Are there all-cause mortality differences between metabolic dysfunction-associated steatotic liver disease subtypes?","volume":"80","author":"Li","year":"2024","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T16:48:29Z","timestamp":1732466909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1089326124000503"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol and Metabolic Syndrome Interaction","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}